Elmar R. Burchardt
Corporate Officer/Principal bij University of Witten/Herdecke
Profiel
Elmar R.
Burchardt is currently an Associate Professor at the University of Witten.
Previously, he held positions as the Chief Executive Officer & Director at TheraVitae, Inc., President, Chief Executive Officer & Director at Hemostemix, Inc., Medical Director at Miltenyi GmbH, Vice President-Medical Affairs at Vericel Corp., and Senior Research Group Leader at Bayer AG.
He obtained his graduate and doctorate degrees from Hannover Medical School.
Actieve functies van Elmar R. Burchardt
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Witten/Herdecke | Corporate Officer/Principal | - |
Eerdere bekende functies van Elmar R. Burchardt
| Bedrijven | Functie | Einde |
|---|---|---|
| HEMOSTEMIX INC. | Algemeen Directeur | 25-01-2017 |
| VERICEL CORPORATION | Hoofd Techniek/Wetenschap/O&O | 30-05-2010 |
TheraVitae, Inc.
 TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Algemeen Directeur | - |
Miltenyi GmbH
 Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Hoofd Techniek/Wetenschap/O&O | - |
| BAYER AG | Corporate Officer/Principal | - |
Opleiding van Elmar R. Burchardt
| Hannover Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| BAYER AG | Health Technology |
| HEMOSTEMIX INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
